Trade Mark Journal No.2026/036 4 September 2026

WO0000001932623 (5,42)

Office of origin: United States of America

Date of International Registration:18 June 2026
Date of designation in the UK: 18 June 2026
Image for mark 1932623 TARSUS

International priority date claimed: 22 December 2025 (United States of America) (99562062)
Class 5
Ophthalmic preparations; preparations for destroying parasites; pharmaceutical preparations for the treatment of Demodex blepharitis; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions.
Class 42
Pharmaceutical research and development; providing medical and scientific research information; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research via a website.

Tarsus Pharmaceuticals, Inc.

Representative: Knobbe, Martens, Olson & Bear, LLP Knobbe, Martens, Olson & Bear, LLP, 2040 Main St., 14th Floor, Irvine CA 92614, UNITED STATES OF AMERICA